Skip to content
10-Q

Quarterly Report

LIGAND PHARMACEUTICALS INC LGND LGNDZ LGNXZ LGNYZ LGNZZ

0000886163-25-000051

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 19.6M sh
Shares Diluted Q2 2025 · Jun 30, 2025 19.93M sh
Shares Diluted Q2 2025 · Jun 30, 2025 19.26M sh
Shares Diluted Q2 2025 · Jun 30, 2024 18.03M sh
Shares Diluted Q2 2025 · Jun 30, 2024 18.28M sh
Capex Q2 2025 · Jun 30, 2025 $428K
Capex Q2 2025 · Jun 30, 2024 $513K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$9.65M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $32.05M
Short Term Investments Q2 2025 · Jun 30, 2025 $177.35M
Short Term Investments Q2 2025 · Dec 31, 2024 $183.86M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $67.67M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $72.31M
Stockholders Equity Q2 2025 · Jun 30, 2025 $828.53M
Stockholders Equity Q2 2025 · Mar 31, 2025 $795.53M
Stockholders Equity Q2 2025 · Dec 31, 2024 $830.44M
Stockholders Equity Q2 2025 · Jun 30, 2024 $775.2M
Stockholders Equity Q2 2025 · Mar 31, 2024 $806.52M
Stockholders Equity Q2 2025 · Dec 31, 2023 $700.91M
Current Liabilities Q2 2025 · Jun 30, 2025 $64.73M
Current Liabilities Q2 2025 · Dec 31, 2024 $37.11M
Total Liabilities Q2 2025 · Jun 30, 2025 $120.08M
Total Liabilities Q2 2025 · Dec 31, 2024 $111.34M
Current Assets Q2 2025 · Jun 30, 2025 $352.95M
Current Assets Q2 2025 · Dec 31, 2024 $331.56M
Total Assets Q2 2025 · Jun 30, 2025 $948.6M
Total Assets Q2 2025 · Dec 31, 2024 $941.77M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.24
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.95
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.88
Eps Diluted Q2 2025 · Jun 30, 2024 $1.87
Eps Basic Q2 2025 · Jun 30, 2025 $0.25
Eps Basic Q2 2025 · Jun 30, 2025 −$1.95
Eps Basic Q2 2025 · Jun 30, 2024 −$2.88
Eps Basic Q2 2025 · Jun 30, 2024 $1.91
Sga Expense Q2 2025 · Jun 30, 2025 $20.18M
Sga Expense Q2 2025 · Jun 30, 2025 $38.98M
Sga Expense Q2 2025 · Jun 30, 2024 $17.62M
Sga Expense Q2 2025 · Jun 30, 2024 $28.57M
Rd Expense Q2 2025 · Jun 30, 2025 $6.57M
Rd Expense Q2 2025 · Jun 30, 2025 $56.65M
Rd Expense Q2 2025 · Jun 30, 2024 $5.35M
Rd Expense Q2 2025 · Jun 30, 2024 $11.33M
Net Income Q2 2025 · Jun 30, 2025 $4.85M
Net Income Q2 2025 · Jun 30, 2025 −$37.6M
Net Income Q2 2025 · Mar 31, 2025 −$42.45M
Net Income Q2 2025 · Jun 30, 2024 −$51.91M
Net Income Q2 2025 · Jun 30, 2024 $34.23M
Net Income Q2 2025 · Mar 31, 2024 $86.14M
Operating Income Q2 2025 · Jun 30, 2025 $8.44M
Operating Income Q2 2025 · Jun 30, 2025 −$27.77M
Operating Income Q2 2025 · Jun 30, 2024 −$19.1M
Operating Income Q2 2025 · Jun 30, 2024 −$16.11M
Revenue Q2 2025 · Jun 30, 2025 $47.63M
Revenue Q2 2025 · Jun 30, 2025 $92.96M
Revenue Q2 2025 · Jun 30, 2024 $41.53M
Revenue Q2 2025 · Jun 30, 2024 $72.51M